---
title: "Gossamer Bio shareholders approve charter amendment increasing authorized common shares to 4 billion"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292750380.md"
description: "Gossamer Bio shareholders approved a charter amendment increasing authorized common shares to 4 billion from 700 million. The company also adopted an amended 2019 Incentive Award Plan and authorized share issuances linked to convertible notes and warrants. Additionally, investors backed alternate amendments for a potential reverse stock split."
datetime: "2026-07-15T10:26:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292750380.md)
  - [en](https://longbridge.com/en/news/292750380.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292750380.md)
---

# Gossamer Bio shareholders approve charter amendment increasing authorized common shares to 4 billion

-   Gossamer Bio held a special shareholder meeting on July 14, 2026. \* Shareholders authorized potential share issuance tied to conversion of up to $72 million of 7.50% Convertible Senior Secured First Lien Notes due 2030 and exercise of 135,789,000 warrants. \* Investors adopted an amended and restated 2019 Incentive Award Plan, increasing the shares reserved for issuance under the plan. \* Shareholders authorized a charter amendment raising authorized common shares to 4,000,000,000 from 700,000,000; the amendment was filed and became effective. \* Investors also backed alternate charter amendments permitting a reverse stock split with a proportionate cut in authorized shares; no execution was confirmed. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gossamer Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001728117-26-000061), on July 15, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [GOSS.US](https://longbridge.com/en/quote/GOSS.US.md)

## Related News & Research

- [Gossamer Bio shareholders approved convertible note exchange proposals at special meeting](https://longbridge.com/en/news/293920719.md)
- [Gossamer Bio Restructures Debt, Secures Full Control of Lead Drug Candidate](https://longbridge.com/en/news/293964802.md)
- [NanoViricides issues warrants exercisable at US$1.75 in US$3.8 million registered direct offering](https://longbridge.com/en/news/294342376.md)
- [Inhibikase swaps 18,030,000 shares for RA Capital pre-funded warrant in unregistered offering](https://longbridge.com/en/news/294255122.md)
- [Vyne Therapeutics issues pre-funded warrants for 133,290 shares in stock exchange deal](https://longbridge.com/en/news/294409414.md)